Gourt > Health > Pharmacy > Drugs and Medications > D > Didanosine
Didanosine (2'-3'-dideoxyinosine, ddI) is sold under the trade names Videx® and Videx EC®. It is a reverse transcriptase inhibitor, effective against HIV and used in combination with other antiretroviral drug therapy as part of highly active antiretroviral therapy (HAART).
History
Didanosine was developed by Samuel Broder, Hiroaki Mitsuya, and Robert Yarchoan in the National Cancer Institute (NCI). Since the NCI cannot market a product, the National Institutes of Health (NIH) awarded a ten-year exclusive licensed to Bristol-Myers Squibb Co. (BMS) to market and sell ddI as Videx® tablets.
Didanosine became the second drug approved for the treatment of HIV infection in many other countries, including in the United States by the Food and Drug Administration (FDA) on Oct 9, 1991. Its FDA approval helped bring down the price of zidovudine (AZT), the initial anti-HIV drug.
More on [ Didanosine ]
@ferbuzz mudah sekali itu kok, cm lamivudine didanosine saquinavir ritonavir enfuvirtide maraviroc raltegravir. udh deh. gampang bgt!
tommywibhowo (Tommy Wibhowo) Sat, 05 Dec 2009 05:04:37 -0000
@ferbuzz mudah sekali itu kok, cm lamivudine didanosine saquinavir ritonavir enfuvirtide maraviroc raltegravir. udh deh. gampang bgt!
ddI - a.k.a. Didanosine, Videx.
Didanosine - (ddI)
Meta Description: [ didanosine (ddI, Videx, Videx EC) ]
DrugDigest: Didanosine - Information on dosage, usage, side effects, interactions, and drug comparisons, including generics when available. Sold under brand names such as: DDI, Videx, and dideoxyinosine.
| FDA Studying Heart Attack Risk with Ziagen, Videx -July 2008 | |
